Biomarkers Can Predict Risk Level for Malignant Glioma Recurrence

Scientists say they have identified specific predictive biomarkers that could help assess the level of risk for recurrence in patients with malignant glioma. The study (“ A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence ”), led by Henry Ford Health System's Department of Neurosurgery and Department of Public Health Sciences, appears in  Cell Reports .“Glioma diagnosis is based on histomorphology and grading; ho